Zosano Pharma Corporation ZSAN

Set alert

Price alert · ZSAN

All alert types
0.56 0.00 0.00%

As of Apr 24, 3:47 PM ET

0.46 Day range 0.635

52-week range unavailable

Open
0.5188
Prev close
0.5576
Mkt cap
0
Vol
1.16M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.46
High
0.635
Forward P/E
-6.20
Beta
3.29
Short ratio
1.18
Inst. own
8.23%
Dividend
0.00
Ex-div date
Earnings
May 13, 2022
50-d avg
1.53
200-d avg
0.92973
1y target
21.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for ZSAN has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 21.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ZSAN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.02-0.02 – -0.02-2.10+99.0%100.00K-61.5%1
Next quarter-0.01-0.01 – -0.01-2.45+99.6%00.0%1
Current year-0.09-0.09 – -0.09-9.45+99.0%200.00K-74.5%1
Next year-0.09-0.09 – -0.09-0.090.0%00.0%1

Upgrades and downgrades

The latest rating changes

ZSAN analyst upgrades and downgrades
DateFirmActionFromTo
Feb 23, 2022BTIGDowngradeBuyNeutral
Mar 15, 2021Maxim GroupMaintained—Buy
Nov 25, 2020HC Wainwright & Co.Maintained—Buy
Oct 2, 2020HC Wainwright & Co.Maintained—Buy
Apr 9, 2020H.C. WainwrightInitiated—Buy
Mar 27, 2020BTIGMaintained—Buy
Nov 15, 2019Cantor FitzgeraldReiterated—Overweight
Apr 23, 2019Cantor FitzgeraldInitiated—Overweight
Apr 17, 2019Maxim GroupInitiated—Buy
Jun 28, 2018BTIG ResearchInitiated—Buy
Aug 11, 2016Ladenburg ThalmannDowngradeBuyNeutral
Mar 5, 2015Ladenburg ThalmannInitiated—Buy
Feb 23, 2015Roth CapitalInitiated—Buy